Eli Lilly’s best-ever weight loss data; Sanofi, Regeneron re-up for $1B upfront; and more
Welcome back to another edition of Endpoints Weekly! It’s October 3rd, the day he asked me what day it was. “It’s October 3rd,” I told him. This week we had a number of prominent deals ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.